rs37060

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016284.5(CNOT1):​c.5896-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.258 in 1,610,182 control chromosomes in the GnomAD database, including 56,368 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4896 hom., cov: 33)
Exomes 𝑓: 0.26 ( 51472 hom. )

Consequence

CNOT1
NM_016284.5 splice_region, intron

Scores

2
Splicing: ADA: 0.000008593
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.590

Publications

40 publications found
Variant links:
Genes affected
CNOT1 (HGNC:7877): (CCR4-NOT transcription complex subunit 1) Enables armadillo repeat domain binding activity; molecular adaptor activity; and nuclear receptor binding activity. Contributes to poly(A)-specific ribonuclease activity. Involved in several processes, including negative regulation of signal transduction; positive regulation of cytoplasmic mRNA processing body assembly; and regulation of gene expression. Located in P-body and cytosol. Part of CCR4-NOT complex. Implicated in holoprosencephaly. [provided by Alliance of Genome Resources, Apr 2022]
CNOT1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • holoprosencephaly 12 with or without pancreatic agenesis
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • Vissers-Bodmer syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-58532400-G-A is Benign according to our data. Variant chr16-58532400-G-A is described in ClinVar as Benign. ClinVar VariationId is 1217372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.367 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNOT1NM_016284.5 linkc.5896-5C>T splice_region_variant, intron_variant Intron 40 of 48 ENST00000317147.10 NP_057368.3 A5YKK6-1
CNOT1NM_001265612.2 linkc.5881-5C>T splice_region_variant, intron_variant Intron 40 of 48 NP_001252541.1 A5YKK6-2
CNOT1NR_049763.2 linkn.6154-5C>T splice_region_variant, intron_variant Intron 40 of 49

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNOT1ENST00000317147.10 linkc.5896-5C>T splice_region_variant, intron_variant Intron 40 of 48 1 NM_016284.5 ENSP00000320949.5 A5YKK6-1

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36906
AN:
151982
Hom.:
4881
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.348
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.382
Gnomad SAS
AF:
0.335
Gnomad FIN
AF:
0.257
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.251
Gnomad OTH
AF:
0.231
GnomAD2 exomes
AF:
0.291
AC:
72945
AN:
250324
AF XY:
0.286
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.452
Gnomad ASJ exome
AF:
0.260
Gnomad EAS exome
AF:
0.384
Gnomad FIN exome
AF:
0.269
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.276
GnomAD4 exome
AF:
0.260
AC:
379032
AN:
1458080
Hom.:
51472
Cov.:
33
AF XY:
0.261
AC XY:
189096
AN XY:
724590
show subpopulations
African (AFR)
AF:
0.148
AC:
4934
AN:
33396
American (AMR)
AF:
0.438
AC:
19531
AN:
44592
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
6717
AN:
26086
East Asian (EAS)
AF:
0.354
AC:
13993
AN:
39544
South Asian (SAS)
AF:
0.319
AC:
27476
AN:
86142
European-Finnish (FIN)
AF:
0.266
AC:
14153
AN:
53288
Middle Eastern (MID)
AF:
0.207
AC:
1189
AN:
5742
European-Non Finnish (NFE)
AF:
0.248
AC:
275166
AN:
1109036
Other (OTH)
AF:
0.263
AC:
15873
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
15676
31352
47029
62705
78381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9476
18952
28428
37904
47380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.243
AC:
36948
AN:
152102
Hom.:
4896
Cov.:
33
AF XY:
0.247
AC XY:
18368
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.158
AC:
6565
AN:
41486
American (AMR)
AF:
0.349
AC:
5336
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.257
AC:
893
AN:
3468
East Asian (EAS)
AF:
0.381
AC:
1968
AN:
5162
South Asian (SAS)
AF:
0.336
AC:
1619
AN:
4822
European-Finnish (FIN)
AF:
0.257
AC:
2711
AN:
10564
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.251
AC:
17098
AN:
68004
Other (OTH)
AF:
0.235
AC:
496
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1415
2830
4244
5659
7074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.253
Hom.:
11466
Bravo
AF:
0.245
Asia WGS
AF:
0.353
AC:
1229
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Vissers-Bodmer syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 12 with or without pancreatic agenesis Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.4
DANN
Benign
0.43
PhyloP100
0.59
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0000086
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs37060; hg19: chr16-58566304; COSMIC: COSV55315818; COSMIC: COSV55315818; API